REFERENCES
- Warren D, Nelson KE, Farrar JA, et al. A large outbreak of epidemic keratoconjunctivitis: problems in controlling nosocomial spread. J Infect Dis. 1989;160:938–943.
- Dart JKG, El-Amir AN, Maddison T, et al. Identification and control of nosocomial adenovirus keratoconjunctivitis in an ophthalmic department. Br J Ophthalmol. 2009;93:18–20.
- Hamada N, Gotoh K, Hara K, et al. Nosocomial outbreak of epidemic keratoconjunctivitis accompanying environmental contamination with adenoviruses. J Hosp Infect. 2008;68:262–268.
- Percivalle E, Sarasini A, Torsellini M, et al. A comparison of methods for detecting adenovirus type 8 keratoconjunctivitis during a nosocomial outbreak in a neonatal intensive care unit. J Clin Virol. 2003;28:257–264.
- Ersoy Y, Otlu B, Türkçüoğlu P, et al. Outbreak of adenovirus serotype 8 conjunctivitis in preterm infants in a neonatal intensive care unit. J Hosp Infect. 2012;80:144–149.
- Yamazaki ES, Ferraz CA, Hazarbassanov RM, et al. Phototherapeutic keratectomy for the treatment of corneal opacities after epidemic keratoconjunctivitis. Am J Ophthalmol. 2011;151:35–43.
- Gonzalez-Lopez JJ, Morcillo-Laiz R, Munoz-Negrete FJ. Adenoviral keratoconjunctivitis: an update. Arch Soc Esp Oftalmol. 2013;88:108–115.
- Kimura R, Migita H, Kadonosono K, et al. Is it possible to detect the presence of adenovirus in conjunctiva before the onset of conjunctivitis? Acta Ophthalmol. 2009;87:44–47.
- Udeh BL, Schneider JE, Ohsfeldt RL. Cost effectiveness of a point-of-care test for adenoviral conjunctivitis. Am J Med Sci. 2008;336:254–264.
- Kaneko H, Maruko I, Iida T, et al. The possibility of human adenovirus detection from the conjunctiva in asymptomatic cases during nosocomial infection. Cornea. 2008;27:527–530.
- Chaberny IF, Schnitzler P, Geiss HK, et al. An outbreak of epidemic keratoconjunctivitis in a pediatric unit due to adenovirus type 8. Infect Control Hosp Epidemiol. 2003;24:514–519.
- Faden H, Wynn RJ, Campagna L, et al. Outbreak of adenovirus type 30 in a neonatal intensive care unit. J Pediatr. 2005;146:523–527.
- Calkavur S, Olukman O, Ozturk AT, et al. Epidemic adenoviral keratoconjunctivitis possibly related to ophthalmological procedures in a neonatal intensive care unit: lessons from an outbreak. Ophthalmic Epidemiol. 2012;19:371–379.
- Gordon YJ, Gordon RY, Romanowski E, et al. Prolonged recovery of desiccated adenoviral serotypes 5, 8, and 19 from plastic and metal surfaces in vitro. Ophthalmology. 1993;100:1835–1839.
- Kanski J. Clinical Ophthalmology: A Systematic Approach. 5th edn. London: Butterworth Heinemann; 2003.
- Jhanji V, Chan TCY, Li EYM, et al. Adenoviral keratoconjunctivitis. Surv Ophthalmol. 2015;60:435–443.
- Kim SY, Chung YK, Lee Y-C, et al. Oral steroid therapy as an adjuvant treatment for severe epidemic keratoconjunctivitis in patients younger than 3 years. Cornea. 2015;34:182–187.
- Bolaños-Jiménez R, Navas A, López-Lizárraga EP, et al. Ocular surface as barrier of innate immunity. Open Ophthalmol J. 2015;9:49–55.
- Ghebremedhin B. Human adenovirus: Viral pathogen with increasing importance. Eur J Microbiol Immunol (Bp). 2014;4:26–33.
- Melendez CP, Florentino MM, Martinez IL, et al. Outbreak of epidemic keratoconjunctivitis caused by adenovirus in medical residents. Mol Vis. 2009;15:557–562.
- Ueta M. Innate immunity of the ocular surface and ocular surface inflammatory disorders. Cornea. 2008;27:31–40.
- Ueta M, Kinoshita S. Innate immunity of the ocular surface. Brain Res Bull. 2010;81:219–228.
- Dosso AA, Rungger-Brandle E. Clinical course of epidemic keratoconjunctivitis. evaluation by in vivo confocal microscopy. Cornea. 2008;27:263–268.
- Walls T, Shankar AG, Shingadia D. Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients. Lancet Infect Dis. 2003;3:79–86.
- Lassiter HA, Watson SW, Seifring ML. Complement factor 9 deficiency in serum of human neonates. J Infect Dis. 1992;53:166–167.
- Weismann LE, Stoll BJ, Kueser TJ, et al. Intravenous immune globulin prophylaxis of late-onset sepsis in premature neonates. J Pediatr. 1994;125:922–930.
- Prescott SL, Macaubas C, Smallacombe T, et al. Reciprocal age-related patterns of allergen-specific T-cell immunity in normal vs. atopic infants. Clin Exp Allergy. 1998; 28(5)39–44.
- Adkins B, Du RQ. Newborn mice develop balanced Th1/Th2 primary effector responses in vivo but are biased to Th2 secondary responses. J Immunol. 1998;160:4217–4224.
- Von Noorden GK. Factors involved in the production of amblyopia. Br J Ophthalmol. 1974;58:158–164.